![Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..](https://oncodaily.com/pub/uploads/2023/10/download-95.jpg)
Photo taken from Nalee Kim/Twitter
Oct 15, 2023, 13:12
Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..
Nalee Kim, Radiation oncologist at Yonsei Cancer Center, shared on X/Twitter:
“We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes.. especially for patients in < 3 lines of systemic Tx and stable extra-breast disease.!”
For details click here.
Source: Nalee Kim/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023